Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05672108 · ClinicalTrials.gov registry record · Phase 2
Phase II Trial of Lung Chemoemobolization
A Phase 2 study of Sarcoma and Colon Cancer, sponsored by City of Hope Medical Center.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT05672108 is a Phase 2 study of Sarcoma and Colon Cancer that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 30 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05672108, a Phase 2 study of Sarcoma and Colon Cancer, is actively recruiting participants, sponsored by City of Hope Medical Center.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This phase II trial evaluates how well transarterial chemoembolization (TACE) works for treating patients with non-small cell lung cancer or lung metastases. TACE is a minimally invasive procedure that involves injecting chemotherapy directly into an artery that supplies blood to tumors, and then blocking off the blood supply to the tumors. Mitomycin (chemotherapy), Lipiodol (drug carrier), and Embospheres (small plastic beads that block off the artery) are injected into the tumor-feeding artery. This traps the chemotherapy inside the tumor and also cuts off the tumor\'s blood supply. As a result, the tumor is exposed to a high dose of chemotherapy, and is also deprived of nutrients and oxygen. TACE can be effective at controlling or stopping the growth of lung tumors.
Conditions Studied
Interventions
- PROCEDURE Computed Tomography
- DRUG Mitomycin
- PROCEDURE Transarterial Chemoembolization
- DRUG Ethiodized Oil
- DEVICE Tris-acryl Gelatin Microspheres
Study Locations (2)
California
- City of Hope Medical Center - Duarte
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-05-12 |
| Est. Completion | 2027-10-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05672108
The ClinicalTrials.gov registry entry for NCT05672108 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (97% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Sarcoma appearing as the primary indexed condition, and to 5 interventions - of which Computed Tomography is the first listed.
NCT05672108 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, New York.
Frequently Asked Questions
What is clinical trial NCT05672108 about?
NCT05672108 is a clinical study titled "Phase II Trial of Lung Chemoemobolization". This phase II trial evaluates how well transarterial chemoembolization (TACE) works for treating patients with non-small cell lung cancer or lung metastases. TACE is a minimally invasive procedure that involves injecting chemotherapy directly into an artery that supplies blood to tumors, and then bl...
What is the current status of trial NCT05672108?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2023-05-12. Estimated completion is 2027-10-28.
What conditions does trial NCT05672108 study?
This clinical trial studies the following conditions: Sarcoma, Colon Cancer, Lung Non-Small Cell Carcinoma, Pleural Neoplasm, Mediastinal Neoplasm.
What interventions are being tested in trial NCT05672108?
The interventions under investigation include: Computed Tomography (PROCEDURE), Mitomycin (DRUG), Transarterial Chemoembolization (PROCEDURE), Ethiodized Oil (DRUG), Tris-acryl Gelatin Microspheres (DEVICE).
Who is sponsoring clinical trial NCT05672108?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05672108 being conducted?
This trial has 2 study locations across California, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RECRUITING · Phase 2
-
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
RECRUITING · Phase 2
-
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
RECRUITING · Phase 2
-
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
RECRUITING · Phase 2
-
Fluorescent Intra-operative Tumor Margin Examination
RECRUITING · Phase 2
-
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.